Learn More
CONTEXT Incidence of human immunodeficiency virus (HIV) in the United States has not been directly measured. New assays that differentiate recent vs long-standing HIV infections allow improved estimation of HIV incidence. OBJECTIVE To estimate HIV incidence in the United States. DESIGN, SETTING, AND PATIENTS Remnant diagnostic serum specimens from(More)
OBJECTIVE To estimate HIV incidence in the United States using a newly developed method. METHODS The analysis period (2002-2011) was broken down into 3-year periods with overlaps, and HIV incidence was estimated based on the relationship between number of new diagnoses and HIV incidence in each of these 3-year periods, by assuming that all HIV infections(More)
Data are presented for diagnoses of HIV infection reported to CDC through December 2012. The HIV Surveillance Supplemental Report is not copyrighted and may be used and copied without permission. Citation of the source is, however, appreciated. Suggested citation Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and(More)
Data classified using quartiles Total rate = 19.1 Note. Data include persons with a diagnosis of HIV infection regardless of the stage of disease at diagnosis. Data have been statistically adjusted to account for reporting delays, but not for incomplete reporting. Acknowledgments Publication of this report would not have been possible without the(More)
HIV incidence estimates are used to monitor HIV-1 infection in the United States. Use of laboratory biomarkers that distinguish recent from longstanding infection to quantify HIV incidence rely on having accurate knowledge of the average time that individuals spend in a transient state of recent infection between seroconversion and reaching a specified(More)
The following 80 abstracts form Part A of two issues of Journal of Automated Methods & Management in Chemistry devoted to abstracts of papers and posters presented this year at the 52nd Pittsburgh Conference, held from 4 to 9 March 2001 in New Orleans, LA, USA. The papers and posters covered a range of topics and techniques, each of which provided valuable(More)
BACKGROUND Published death rates for persons with HIV have not distinguished deaths due to HIV from deaths due to other causes. Cause-specific death rates would allow better assessment of care needs. METHODS Using data reported to the US national HIV surveillance system, we examined a) associations between selected decedent characteristics and causes of(More)
BACKGROUND The best indicator of the impact of human immunodeficiency virus (HIV) prevention programs is the incidence of infection; however, HIV is a chronic infection and HIV diagnoses may include infections that occurred years before diagnosis. Alternative methods to estimate incidence use diagnoses, stage of disease, and laboratory assays of infection(More)